CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q1 2022 Results - Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q1 2022 Earnings Conference Call May 10, 2022 08:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Relations Tony Coles - Chairperson and Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer A. Ceesay - President Conference Call Participants Cory Kasimov - JPMorgan Michael Yee - Jefferies Paul Matteis - Stifel Douglas Tsao - H.C. Wainwright Madhu Kumar - Goldman Sachs Won Jung - Morgan Stanley Esther Hong - Berenberg Presentation Operator Good morning and welcome to the Cerevel Therapeutics first-quarter 2022 financial results conference call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded. I will now hand the call

For further details see:

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2022 Results - Earnings Call Transcript